Having demonstrated that loss of GRP78 promotes the tumorigenic actions of IGFBP-3 in our in vitro experiments we re-grouped our clinical dataset into GRP78 low tumours with either low or high IGFBP-3 staining. Here, HSPA5 is linked to neoplasm.